Sage Bionetworks releases data from Parkinson’s ResearchKit study
The dataset has information captured from more than 9,500 people to help speed scientific progress toward treatments for people with Parkinson's disease.
IBM teams-up with ASAA to launch ResearchKit-based SleepHealth app
The Big Blue has also introduced Watson Health for ResearchKit, which is available at no charge to qualified, non-profit health researchers.
Asthma Health ResearchKit app comes to the UK and Ireland
The application enables individuals with asthma to participate in a largeĀ-scale medical research study by simply using their Apple iPhones.
New ResearchKit app launches to track concussions
The iPhone and Apple Watch app is designed to help those with concussions better track their symptoms during the critical six weeks following their diagnosis.
Japan’s Keio University, COPD Foundation launch ResearchKit studies
The former is looking to use data for the early detection of arrhythmia and cerebral infarction, while the latter aims to collect data from people with COPD.
ResearchStack is ResearchKit for Android
The two SDKs will offer enough shared functionality and a common framework and naming scheme to greatly speed up adaptation of ResearchKit apps to Android.
Yale’s new ResearchKit app aims to prevent pregnancy loss
The ResearchKit-based study seeks to determine whether estimated placental volume (EPV) measurements can be used to predict pregnancy outcome.
New ResearchKit studies for autism, epilepsy and melanoma unveiled
Apple announced that researchers from Duke University, Johns Hopkins and Oregon Health & Science University are launching new medical studies using ResearchKit.
Boston Children’s launches ResearchKit study on hepatitis C
Called C Tracker, the study will give researchers insight into patients' daily activity, monitor symptoms and assess the efficacy of treatments.
Yale School of Medicine launches a ResearchKit app
Yale Cardiomyopathy Index clinical study launching to better understand quality of life for people ages two to 80 who have or may develop a cardiomyopathy.